In her debut blog, Natalie Kashirsky explores a qualitative study finding valuable mechanisms of peer support in early intervention in psychosis services.
[read the full story...]
In her debut blog, Natasha Chilman blogs about a Swedish cohort study of 1.3 million people, which finds that migrants with first episode psychosis are more likely to receive inpatient care.
[read the full story...]
Zuva Dengu summarises a recent Swedish cohort study exploring migrant status and risk of compulsory admission at first diagnosis of psychotic disorder, which suggests that where you are from will influence your experience within psychiatric care.
[read the full story...]
In her debut blog, Rosa Pitts summarises the ARIES trial, which suggests it may be feasible to use a smartphone app (My Journey 3) to help prevent relapse in psychosis, although questions remain about long-term participant engagement with the app.
[read the full story...]
Joe Pierre summarises two recently published and widely reported RCTs, which suggest that antipsychotic medication might not offer an advantage over psychotherapy in broadly-defined first episode psychosis.
[read the full story...]
Danny Whiting explores the issue of screening for first episode psychosis in prison using a retrospective cohort study from Australia.
[read the full story...]
In Joseph Lam’s debut blog he explores a recent research paper which uses an electronic dataset to investigate the relationship between insight and service use in first episode psychosis.
[read the full story...]
A group of UCL Mental Health Masters students summarise the iHOPE-20 study, which looks at relationships between and prospective predictors of remission, clinical recovery, personal recovery and resilience 20 years on from a first episode psychosis.
[read the full story...]
Luke Sheridan-Reins explores a recent paper on the contribution of cannabis use to variation in the incidence of psychotic disorder across Europe.
[read the full story...]
Vishal Bhavsar reviews an EU study of nearly 3,000 people across 6 EU countries, looking at the treated incidence of schizophrenia and psychotic disorders. It helps us better understand who gets psychosis, when, and where.
[read the full story...]
